tiprankstipranks
Rani Therapeutics Holdings options imply 12.6% move in share price post-earnings
PremiumThe FlyRani Therapeutics Holdings options imply 12.6% move in share price post-earnings
4M ago
Rani Therapeutics announces new preclinical PK data on GLP-1
Premium
The Fly
Rani Therapeutics announces new preclinical PK data on GLP-1
5M ago
Rani Therapeutics to sell 3M shares at $3.00 in registered direct offering
Premium
The Fly
Rani Therapeutics to sell 3M shares at $3.00 in registered direct offering
5M ago
Rani Therapeutics initiated with an Outperform at Oppenheimer
PremiumThe FlyRani Therapeutics initiated with an Outperform at Oppenheimer
7M ago
Rani Therapeutics to sell 2.8M shares at $3.08 in registered diect offering
Premium
The Fly
Rani Therapeutics to sell 2.8M shares at $3.08 in registered diect offering
7M ago
Rani Therapeutics Reevaluates Equity Financing Strategy
Premium
Company Announcements
Rani Therapeutics Reevaluates Equity Financing Strategy
8M ago
Rani Therapeutics price target raised to $13 from $12 at H.C. Wainwright
PremiumThe FlyRani Therapeutics price target raised to $13 from $12 at H.C. Wainwright
10M ago
Rani Therapeutics reports Q1 EPS (29c), consensus (20c)
Premium
The Fly
Rani Therapeutics reports Q1 EPS (29c), consensus (20c)
10M ago
Rani Therapeutics management to meet virtually with BTIG
Premium
The Fly
Rani Therapeutics management to meet virtually with BTIG
10M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100